T. Rowe Price Associates »

Kalvista Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $260k 21k 12.27
2023-09-30 $183k 19k 9.65
2023-06-30 $293k 33k 9.01
2023-03-31 $291k 37k 7.87
2022-12-31 $249k 37k 6.75
2022-03-31 $270k 18k 14.73
2021-12-31 $194k 15k 13.23